These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35186240)
1. LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future. Zhu D; Hao Q; Qian M; Hu Y; Wu F J Healthc Eng; 2022; 2022():8387458. PubMed ID: 35186240 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA. Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2. Hou S; Zhang X; Yang J Exp Cell Res; 2022 Jan; 410(1):112929. PubMed ID: 34793775 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway. He D; Yue Z; Liu L; Fang X; Chen L; Han H J Cell Physiol; 2019 Jul; 234(7):12070-12079. PubMed ID: 30537177 [TBL] [Abstract][Full Text] [Related]
5. EZH2-mediated lncRNA ABHD11-AS1 promoter regulates the progression of ovarian cancer by targeting miR-133a-3p. Zhang W; Huang X; Shi J Anticancer Drugs; 2021 Mar; 32(3):269-277. PubMed ID: 33491971 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of lncRNA DCST1-AS1 suppresses proliferation, migration and invasion of cervical cancer cells by increasing miR-874-3p expression. Liu J; Zhang J; Hu Y; Zou H; Zhang X; Hu X J Gene Med; 2021 Jan; 23(1):e3281. PubMed ID: 33025624 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma. Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway. Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304 [TBL] [Abstract][Full Text] [Related]
11. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model. Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882 [TBL] [Abstract][Full Text] [Related]
12. Role of the lncRNA ABHD11-AS Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis. Lei X; Li L; Duan X Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429229 [TBL] [Abstract][Full Text] [Related]
14. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
15. DSCAM-AS1 promotes cervical carcinoma cell proliferation and invasion via sponging miR-338-3p. Li C; Li X; Zhang Y; Wu L; He J; Jiang N; Zhao H; Liu W Environ Sci Pollut Res Int; 2022 Aug; 29(39):58906-58914. PubMed ID: 35378649 [TBL] [Abstract][Full Text] [Related]
16. m Bian Y; Xu S; Gao Z; Ding J; Li C; Cui Z; Sun H; Li J; Pu J; Wang K Cancer Lett; 2024 Aug; 596():217004. PubMed ID: 38838765 [TBL] [Abstract][Full Text] [Related]
17. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer. Zhang WY; Liu YJ; He Y; Chen P J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p. Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904 [TBL] [Abstract][Full Text] [Related]
19. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Zhou Y; Feng D; Gu X; Gao A; Liu Y Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416 [TBL] [Abstract][Full Text] [Related]
20. LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway. Cai Y; Huang Y; Zhang J; Liu X; Zhao F; Zhang K; Xu S; Yang Y; Huang H; Gao Y Neoplasma; 2022 Dec; 69(6):1406-1417. PubMed ID: 36591804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]